To the Editor: Moynihan and colleagues1 make a good case for Australia responding to the complex challenge of reducing the overdiagnosis of clinical disease. However, this challenge should not lead to confusion with the early diagnosis of and the early intervention in preclinical disease, which are the mainstay of secondary prevention. While reducing diagnosis creep and expanding disease definitions are predominantly the realm of the specialist disciplines, primary care is uniquely placed to embrace preclinical disease diagnosis, increasing early detection and intervention, while specialists endorse reducing overdiagnosis, both collaborating in lowering long term costs to the health system.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Moynihan R, Barratt AL, Buchbinder R, et al. Australia is responding to the complex challenge of overdiagnosis. Med J Aust 2018; 209: 332–334. https://www.mja.com.au/journal/2018/209/8/australia-responding-complex-challenge-overdiagnosis
- 2. Bansal N. Prediabetes diagnosis and treatment: a review. World J Diabetes 2015; 6: 296–303.
- 3. American Diabetes Association. Diagnosing diabetes and learning about prediabetes [website]. Arlington, VA: ADA, 2018. http://www.diabetes.org/diabetes-basics/diagnosis (viewed Oct 2018).
- 4. Diabetes Australia. Pre‐diabetes [website]. Canberra: Diabetes Australia, 2015. https://www.diabetesaustralia.com.au/pre-diabetes (viewed Oct 2018).
- 5. Department of Health. Medicare Benefits Schedule (MBS) Review [website]. Canberra: Commonwealth of Australia; 2015. http://www.health.gov.au/internet/main/publishing.nsf/content/mbsreviewtaskforce (viewed Oct 2018).
- 6. Sayburn A. Lifestyle medicine: a new medical specialty? BMJ 2018; 363: k4442.
No relevant disclosures.